Raia Drogasil S.A. (RADLY) Q4 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Olá a todas e a todos. Hello, everyone. Thank you for standing by and welcome to RD Saúde's fourth quarter 2025 earnings conference call. This presentation can be found on RD Saud's Investor Relations website at ri.rdsaude.com.br, where the replay for this conference will also be made available later. All participants will be in a listen-only mode during the presentation. After the presentation, we will begin the question-and-answer session. Before proceeding, I'd like to mention that forward-looking statements are being made under the safe harbor of the Securities Litigation Reform Act of 1996. Forward-looking statements are based on the beliefs and assumptions of RD Saudis management and on information currently available to the company. Forward-looking statements are not guarantees of performance. They involve risks, uncertainties, and assumptions, as they relate to future events and therefore depend on circumstances that may or may not occur. Our investors should understand that general economic conditions, industry conditions, and other operating factors could also affect the future results of our DSAO day, and could cause results to differ materially from those expressed in such forward-looking statements. Today, joining us from the RD Saúde Studio are Mr. Renato Raduan, CEO, and Mr. Flavio Correa, CIO and Corporate Affairs Chief Officer. Good morning. Turn it over now to Mr. Renato Raduan. Hello. Good morning, everybody. Thank you very much for joining us in the 4Q25 earnings call. We're here to take your questions, give an overview of the business, and do our best to clarify any questions you might have. Hello, Flavio. How's it going? I expect a lot of questions. I hope you had a good night's sleep, Flavio, because I believe we're going to have many questions...